Found 1305 matching trials
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
PHASE2Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Location
Fudan University Shanghai Cancer Center
COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)
N/APatients with loco-regional NSCLC planned for curative treatment with chemo...
Location
Odense University Hospital
Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer
PHASE2This is a single arm Phase II study, in which 6 cycles of durvalumab with c...
Location
Beijing Haidian Hospital
Bladder Cancer Adjuvant Radiotherapy Trial
PHASE3Aim and objectives:
This trial aims to evaluate the role of adjuvant radio...
Status
Active Not Recruiting
Location
Tata Memorial Centre
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
PHASE2Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Location
Highlands Oncology Group
Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers
PHASE3This is a randomized, multicenter, phase III trial comparing induction chem...
Location
Hôpital de la Pitié-Salpétrière
Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma
PHASE2The aim of the study is to determine if intervening with combined local the...
Location
Fudan Universtiy Shanghai Cancer Center
Completely Abdominal Approach Laparoscopic Partial Intersphincteric Resection for Rectal Cancer
NAThe conventional intersphincteric resection (ISR) for low rectal cancer req...
Location
Zhongnan Hospital, Wuhan University
Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC
PHASE2This phase II trial compares the effect of adding radiation therapy to the ...
Location
Zhejiang Cancer Hospital
HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)
PHASE2Patients with intrahepatic cholangiocarcinoma (IHC) have relatively aggress...
Location
Oslo University Hospital